Influenza Diagnosis, Treatment and Surveillance With Xpert Flu

ClinicalTrials.gov ID: NCT01947049

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01947049. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to: 1. Evaluate the clinical performance of a newly available highly-sensitive rapid influenza test, Xpert Flu. 2. Derive and validate an adult clinical decision guideline to guide clinical testing of influenza patients who meed CDC criteria for antiviral treatment. 3. Evaluate impact of rapid influenza testing for antiviral treatment. 4. Determine cost effectiveness of influenza testing and treatment strategies.

Study identification

NCT ID: NCT01947049
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Johns Hopkins University; Other
Enrollment: 2,011 participants

Conditions and interventions

Conditions

Influenza

Interventions

Rapid Influenza Testing with Xpert Flu Other

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 2013 (Type not available)
Primary completion: Jun 30, 2014 (Actual)
Completion: Jun 30, 2014 (Actual)
Last update posted: Sep 18, 2017

2013 – 2014

United States locations

U.S. sites: 4
U.S. states: 4
U.S. cities: 4

Facility	City	State	ZIP	Site status
Maricopa Medical Center	Phoenix	Arizona	85008	—
Olive View - UCLA Medical Center	Sylmar	California	91342	—
Johns Hopkins Hospital	Baltimore	Maryland	21287	—
Truman Medical Center	Kansas City	Missouri	64108	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01947049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 18, 2017 · Synced Nov 14, 2026